Ypsomed is the leading independent developer and manufacturer of user-friendly self-injection systems. To complement our innovative and reliable pen systems for the injection of insulin, hGH, FSH and PTH provides a complete range of dual-chamber pen and syringe-based auto-injector platforms for monodose injections.
Ypsomed unique ‘click-on’ pen needles and safety pen needles are compatible with our own and all other widely available pens. A broad-based technology platform and over 250 patent families mean Ypsomed can meet virtually all customer needs in the growing market for self-injection systems.